The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone

BACKGROUND AND PURPOSE Endocannabinoids in the midbrain periaqueductal grey (PAG) modulate nociception and unconditioned stress‐induced analgesia; however, their role in fear‐conditioned analgesia (FCA) has not been examined. The present study examined the role of the endocannabinoid system in the dorsolateral (dl) PAG in formalin‐evoked nociceptive behaviour, conditioned fear and FCA in rats.

[1]  Stephen P. H. Alexander,et al.  Guide to Receptors and Channels (GRAC), 5th edition , 2011, British journal of pharmacology.

[2]  D. Finn.  Endocannabinoid-mediated modulation of stress responses: physiological and pathophysiological significance. , 2010, Immunobiology.

[3]  C. Grundschober,et al.  Examining face and construct validity of a noninvasive model of panic disorder in Lister-hooded rats , 2010, Psychopharmacology.

[4]  D. Finn,et al.  Effects of intra‐basolateral amygdala administration of rimonabant on nociceptive behaviour and neuronal activity in the presence or absence of contextual fear , 2010, European journal of pain.

[5]  A. Hohmann,et al.  The endocannabinoid system and pain. , 2009, CNS & neurological disorders drug targets.

[6]  D. Finn,et al.  Alterations in extracellular levels of gamma-aminobutyric acid in the rat basolateral amygdala and periaqueductal gray during conditioned fear, persistent pain and fear-conditioned analgesia. , 2009, The journal of pain : official journal of the American Pain Society.

[7]  J. Katz,et al.  Understanding the co‐occurrence of anxiety disorders and chronic pain: state‐of‐the‐art , 2009, Depression and anxiety.

[8]  B. Gorzalka,et al.  Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress , 2009, Psychoneuroendocrinology.

[9]  Ryan K. Butler,et al.  Stress-induced analgesia , 2009, Progress in Neurobiology.

[10]  R. Treede,et al.  Differentiation of pain ratings in combat-related posttraumatic stress disorder , 2009, PAIN®.

[11]  F. Guimarães,et al.  Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray , 2009, European Neuropsychopharmacology.

[12]  A. Haghparast,et al.  Effects of electrolytic lesion of dorsolateral periaqueductal gray on analgesic response of morphine microinjected into the nucleus cuneiformis in rat , 2009, Neuroscience Letters.

[13]  F. Guimarães,et al.  Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved? , 2008, Neural plasticity.

[14]  D. Finn,et al.  Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: Opioid receptor dependency and molecular correlates , 2008, PAIN.

[15]  D. Finn,et al.  Clinical correlates of stress-induced analgesia: Evidence from pharmacological studies , 2008, PAIN.

[16]  F. Guimarães,et al.  Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. , 2008, European journal of pharmacology.

[17]  F. Guimarães,et al.  Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats , 2008, Psychopharmacology.

[18]  B. Cravatt,et al.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. , 2008, Chemical reviews.

[19]  F. Rossi,et al.  Role of TRPV1 receptors in descending modulation of pain , 2008, Molecular and Cellular Endocrinology.

[20]  M. Brandão,et al.  Regulation of conditioned and unconditioned fear in rats by 5-HT1A receptors in the dorsal periaqueductal gray , 2008, Pharmacology Biochemistry and Behavior.

[21]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.

[22]  B. Lumb,et al.  Descending control of spinal nociception from the periaqueductal grey distinguishes between neurons with and without C-fibre inputs , 2008, Pain.

[23]  D. Finn,et al.  The effect of CB1 receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats , 2007, The European journal of neuroscience.

[24]  G. Marsicano,et al.  The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. , 2007, Pharmacological research.

[25]  F. Guimarães,et al.  Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray , 2007, Neuropharmacology.

[26]  K. Ressler,et al.  Modulation of Fear and Anxiety by the Endogenous Cannabinoid System , 2007, CNS Spectrums.

[27]  T. Bisogno,et al.  Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats , 2007, Neuropharmacology.

[28]  D. Finn,et al.  Behavioral, central monoaminergic and hypothalamo–pituitary–adrenal axis correlates of fear-conditioned analgesia in rats , 2006, Neuroscience.

[29]  G. Gessa,et al.  Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404 , 2006, Neuropsychopharmacology.

[30]  K. Mackie,et al.  Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain , 2006, Pain.

[31]  F. Guimarães,et al.  Antidepressant treatment reduces Fos-like immunoreactivity induced by swim stress in different columns of the periaqueductal gray matter , 2006, Brain Research Bulletin.

[32]  B. Lumb,et al.  Midbrain control of spinal nociception discriminates between responses evoked by myelinated and unmyelinated heat nociceptors in the rat , 2006, Pain.

[33]  C. Hillard,et al.  Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling , 2006, Journal of Pharmacology and Experimental Therapeutics.

[34]  A. Hohmann,et al.  Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia , 2006, Neuroscience Letters.

[35]  T. Bisogno,et al.  Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 Receptors , 2006, Journal of Pharmacology and Experimental Therapeutics.

[36]  F. Rossi,et al.  Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat , 2005, Neuroscience.

[37]  A. Hohmann,et al.  Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: Sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla , 2005, Neuropharmacology.

[38]  L. Bertoglio,et al.  Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats , 2005, Brain Research.

[39]  J. Crystal,et al.  An endocannabinoid mechanism for stress-induced analgesia , 2005, Nature.

[40]  D. Finn,et al.  Evidence for differential modulation of conditioned aversion and fear‐conditioned analgesia by CB1 receptors , 2004, The European journal of neuroscience.

[41]  D. Finn,et al.  Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats , 2003, Neuropharmacology.

[42]  J. F. Krey,et al.  Endocannabinoids and related fatty acid derivatives in pain modulation. , 2002, Chemistry and physics of lipids.

[43]  M. Brandão,et al.  Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats , 2002, Psychopharmacology.

[44]  W. Zieglgänsberger,et al.  The endogenous cannabinoid system controls extinction of aversive memories , 2002, Nature.

[45]  B. Cravatt,et al.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  W. A. Prado,et al.  Role of PAG in the antinociception evoked from the medial or central amygdala in rats , 2001, Brain Research Bulletin.

[47]  E. E. Bagley,et al.  Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. , 2000, Molecular pharmacology.

[48]  J. Lee,et al.  Lidocaine blockade of amygdala output in fear-conditioned rats reduces Fos expression in the ventrolateral periaqueductal gray , 1999, Neuroscience.

[49]  J. Walker,et al.  Pain modulation by release of the endogenous cannabinoid anandamide. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Brandão,et al.  Neurochemical mechanisms of the defensive behavior in the dorsal midbrain , 1999, Neuroscience & Biobehavioral Reviews.

[51]  Joseph E LeDoux,et al.  Lesions of periaqueductal gray dissociate-conditioned freezing from conditioned suppression behavior in rats. , 1999, Learning & memory.

[52]  N. Canteras,et al.  Fos-like immunoreactivity in the periaqueductal gray of rats exposed to a natural predator. , 1999, Neuroreport.

[53]  K. Mackie,et al.  Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system , 1998, Neuroscience.

[54]  Joseph E LeDoux.  Fear and the brain: where have we been, and where are we going? , 1998, Biological Psychiatry.

[55]  P. Bellgowan,et al.  Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla , 1998, Brain Research.

[56]  Richard J Bodnar,et al.  Opioid supraspinal analgesic synergy between the amygdala and periaqueductal gray in rats , 1998, Brain Research.

[57]  T. Coderre,et al.  Optimal scoring strategies and weights for the formalin test in rats , 1997, Pain.

[58]  G Paxinos,et al.  Conditioned fear to context is associated with increased Fos expression in the caudal ventrolateral region of the midbrain periaqueductal gray. , 1997, Neuroscience.

[59]  Stephen P. Mayfield,et al.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides , 1996, Nature.

[60]  M. Koch,et al.  Lesions of the central gray block conditioned fear as measured with the potentiated startle paradigm , 1996, Behavioural Brain Research.

[61]  J. Stamford.  Descending control of pain. , 1995, British journal of anaesthesia.

[62]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[63]  FJ Helmstetter,et al.  Lesions of the periaqueductal gray and rostral ventromedial medulla disrupt antinociceptive but not cardiovascular aversive conditional responses , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[64]  F. Helmstetter,et al.  Stress-induced hypoalgesia and defensive freezing are attenuated by application of diazepam to the amygdala , 1993, Pharmacology Biochemistry and Behavior.

[65]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[66]  G Vassart,et al.  Molecular cloning of a human cannabinoid receptor which is also expressed in testis. , 1991, The Biochemical journal.

[67]  M. Herkenham,et al.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[68]  F. Helmstetter,et al.  Conditional hypoalgesia is attenuated by Naltrexone applied to the periaqueductal gray , 1990, Brain Research.

[69]  L. Schenberg,et al.  Logistic analysis of the defense reaction induced by electrical stimulation of the rat mesencephalic tectum , 1990, Neuroscience & Biobehavioral Reviews.

[70]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[71]  Joseph E LeDoux,et al.  Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[72]  M. Fanselow,et al.  Conditional analgesia, defensive freezing, and benzodiazepines. , 1988, Behavioral neuroscience.

[73]  M. Fanselow,et al.  Effects of naltrexone on learning and performance of conditional fear-induced freezing and opioid analgesia , 1987, Physiology & Behavior.

[74]  R. Bandler,et al.  Indentification of midbrain neurones mediating defensive behaviour in the rat by microinjections of excitatory amino acids , 1985, Behavioural Brain Research.

[75]  L. Watkins,et al.  Fear is not critical to classically conditioned analgesia: The effects of periaqueductal gray lesions and administration of chlordiazepoxide , 1984, Brain Research.

[76]  M. Meucci,et al.  Dorsolateral PAG neurons: Tonic immobility and morphine effect in freely moving rabbits , 1983, Physiology & Behavior.

[77]  Eric Vermetten,et al.  Altered pain processing in veterans with posttraumatic stress disorder. , 2007, Archives of general psychiatry.

[78]  S. Gaetani,et al.  Modulation of anxiety through blockade of anandamide hydrolysis , 2003, Nature Medicine.

[79]  M. Brandão,et al.  Anatomical connections of the periaqueductal gray: specific neural substrates for different kinds of fear. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[80]  R. Bandler,et al.  Columnar organization in the midbrain periaqueductal gray and the integration of emotional expression. , 1996, Progress in brain research.

[81]  T. Sugiura,et al.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.

[82]  F. Graeff,et al.  Defensive behavior and hypertension induced by glutamate in the midbrain central gray of the rat. , 1985, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[83]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .